Table 4.

Outcomes in the BRSS and non-BRSS groups

	BRSS group	non-BRSS group	p-value
	n = 24	n = 70
Major bleeding events, n (%)	1 (4.2)	4 (5.7)	1.000
Minor bleeding events, n (%)	1 (4.2)	19 (27.1)	0.020
VTE, n (%)	1 (4.2)	6 (8.6)	0.674
Inappropriate use, n (%)	2 (8.3)	12 (17.1)	0.507
Contraindication, n (%)	0 (0)	0 (0)	NA
Contraindicated medicines, n (%)	0 (0)	0 (0)	NA
Off-label use, n (%)	2 (8.3)	9 (12.9)	0.723
Under dosing, n (%)	0 (0)	2 (2.9)	1.000
Over dosing, n (%)	0 (0)	1 (1.4)	1.000
Length of stay in emergency center, median (IQR)	17.5 (13.5–39.0)	19.50 (14.3–32.8)	0.696
Hospital length of stay, median (IQR)	43.5 (28.5–72.8)	48.5 (36.0–59.8)	0.955
The duration of prophylactic anticoagulation, median (IQR)	11.5 (7.0–14.0)	14.0 (11.3–14.0)	0.004

IQR interquartile range, VTE venous thromboembolism